Akash Patnaik
Assistant Professor of Medicine/Attending Physician
University of Chicago
United States
Has grant
This profile is automatically generated from trusted academic sources.
Google Scholar
.
ORCID
.
How do Nigerian students reach out?
Sign in for free to see their profile details and contact information.
Contact this professor
Research Interests
Pharmacotherapy
Immunology
Cancer Therapy
Prostate Cancer
Immunotherapy
Cancer Biology
Targeted Therapy
Ask ApplyKite AI
Recent Grants
Grant: Open
Targeting the cGAS/STING Pathway to Overcome Resistance to Immune Checkpoint Inhibitors in PTEN-deficient Prostate Cancer.
Open Date: 2022-10-01
Close Date: 2027-09-01
Grant: Close
Activating the NLRP3 Inflammasome to Treat Advanced Prostate Cancer
Open Date: 2022-08-01
Close Date: 2023-07-01
Grant: Close
A Phase 2 Multiple Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb®20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration Resistant Prostate Cancer
Open Date: 2022-07-01
Close Date: 2023-06-01
Grant: Close
Investigating the Therapeutic Potential for STING Agonists to Overcome Resistance to Immune Checkpoint Blockade in PTEN-deficient Prostate Cancer
Open Date: 2021-11-01
Close Date: 2024-10-01
Grant: Close
Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Characterised by PTEN deficiency (CAPItello-281).
Open Date: 2021-06-01
Close Date: 2023-05-01
Articles11
Collaborators4
Natalie Reizine
Assistant Professor
University of Chicago
Leonard Appleman
Associate Professor
University of Pittsburgh
John Clohessy
Assistant Professor
Harvard Medical School
Tomas Kirchhoff
Assistant Professor of Population Health and Environmental Medicine
NYU School of Medicine
How do Nigerian students reach out?
Sign in for free to see their profile details and contact information.